Fine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity

Aida Ferreiro-Iglesias(Centre international de recherche sur le cancer), Corina Lesseur(Centre international de recherche sur le cancer), James McKay(Centre international de recherche sur le cancer), Rayjean J. Hung(University of Toronto), Younghun Han(Dartmouth College), Xuchen Zong(University of Toronto), David C. Christiani(Harvard University), Mattias Johansson(Centre international de recherche sur le cancer), Xiangjun Xiao(Dartmouth College), Yafang Li(Dartmouth College), David C. Qian(Dartmouth College), Xuemei Ji(Dartmouth College), Geoffrey Liu(University of Toronto), Neil E. Caporaso(National Institutes of Health), Ghislaine Scélo(Centre international de recherche sur le cancer), Давид Заридзе(Russian Cancer Research Center NN Blokhin), Anush Mukeriya(Russian Cancer Research Center NN Blokhin), Milica Kontić(Centar za Promociju Nauke), Simona Ognjanovic, Jolanta Lissowska(The Maria Sklodowska-Curie National Research Institute of Oncology), Małgorzata Szołkowska, Beata Świątkowska(Nofer Institute of Occupational Medicine), Vladimí­r Janout(University Hospital Olomouc), Ivana Holcátová(Charles University), Ciprian Bolca(Institutul de Pneumoftiziologie "Marius Nasta"), Milan Savić(Centar za Promociju Nauke), Miodrag Ognjanovic, Stig E. Bojesen(University of Copenhagen), Xifeng Wu(The University of Texas MD Anderson Cancer Center), Demetrius Albanes(National Institutes of Health), Melinda C. Aldrich(Vanderbilt University Medical Center), Adonina Tardón(Universidad de Oviedo), Ana Fernández‐Somoano(Universidad de Oviedo), Guillermo Fernández‐Tardón(Universidad de Oviedo), Loı̈c Le Marchand(University of Hawaiʻi at Mānoa), Gad Rennert(Carmel Medical Center), Chu Chen(University of Washington), Jennifer A. Doherty(University of Washington), Gary E. Goodman(Swedish Medical Center), Heike Bickeböller(University of Göttingen), H‐Erich Wichmann(Helmholtz Zentrum München), Angela Risch(University of Salzburg), Albert Rosenberger(University of Göttingen), Hongbing Shen(Nanjing Medical University), Juncheng Dai(Nanjing Medical University), John K. Field(University of Liverpool), Michael P.A. Davies(University of Liverpool), Penella J. Woll(University of Sheffield), M. Dawn Teare(University of Sheffield), Lambertus A. Kiemeney(Radboud University Nijmegen), Erik H.F.M. van der Heijden(Radboud University Nijmegen), Jian‐Min Yuan(UPMC Hillman Cancer Center), Yun‐Chul Hong(Seoul National University), Aage Haugen(National Institute of Occupational Health), Shanbeh Zienolddiny(National Institute of Occupational Health), Stephen Lam(BC Cancer Agency), Ming‐Sound Tsao(Princess Margaret Cancer Centre), Mikael Johansson(Centre international de recherche sur le cancer), Kjell Grankvist(Umeå University), Matthew B. Schabath(Moffitt Cancer Center), Angeline S. Andrew(Dartmouth College), Eric J. Duell(Institut d'Investigació Biomédica de Bellvitge), Olle Melander(Malmö University), Hans Brunnström(Lund University), Philip Lazarus(Washington State University Spokane), Susanne M. Arnold(University of Kentucky), Stacey Slone(University of Kentucky), Jinyoung Byun(Dartmouth College), Ahsan Kamal(Dartmouth College), Dakai Zhu(Dartmouth College), Maria Teresa Landi(National Institutes of Health), Christopher I. Amos(Dartmouth College), Paul Brennan(Centre international de recherche sur le cancer)
Nature Communications
September 19, 2018
Cited by 59Open Access
Full Text

Abstract

Lung cancer has several genetic associations identified within the major histocompatibility complex (MHC); although the basis for these associations remains elusive. Here, we analyze MHC genetic variation among 26,044 lung cancer patients and 20,836 controls densely genotyped across the MHC, using the Illumina Illumina OncoArray or Illumina 660W SNP microarray. We impute sequence variation in classical HLA genes, fine-map MHC associations for lung cancer risk with major histologies and compare results between ethnicities. Independent and novel associations within HLA genes are identified in Europeans including amino acids in the HLA-B*0801 peptide binding groove and an independent HLA-DQB1*06 loci group. In Asians, associations are driven by two independent HLA allele sets that both increase risk in HLA-DQB1*0401 and HLA-DRB1*0701; the latter better represented by the amino acid Ala-104. These results implicate several HLA-tumor peptide interactions as the major MHC factor modulating lung cancer susceptibility.


Related Papers

No related papers found

Powered by citation graph analysis